In a significant victory for a Fortune 50 pharmaceutical company, the 3rd U.S. Circuit Court of Appeals vacated the trial court's class certification order following a nationwide class action alleging the company fixed the price of blood reagents. Our firm represented the pharmaceutical company in the litigation.
Results may vary depending on your particular facts and legal circumstances.
Fortune 50 Pharmaceutical Company Defeats Class Certification
Lead Contacts
